| | |
Per share and
accompanying warrant |
| |
Per pre-funded
warrant and accompanying warrant |
| |
Total
|
| |||||||||
Offering price | | | | $ | 4.90 | | | | | $ | 4.8999 | | | | | $ | 204,997,450 | | |
Placement agent fees(1) | | | | $ | 0.2205 | | | | | $ | 0.2205 | | | | | $ | 9,224,885 | | |
轉至學者巖石控股公司,未計費用 | | | | $ | 4.6795 | | | | | $ | 4.6794 | | | | | $ | 195,772,565 | | |
| | |
S-Page
|
| |||
About this prospectus
|
| | | | S-ii | | |
Prospectus summary
|
| | | | S-1 | | |
Risk factors
|
| | | | S-16 | | |
有關前瞻性陳述的告誡聲明
|
| | | | S-19 | | |
Use of proceeds
|
| | | | S-21 | | |
Dividend policy
|
| | | | S-22 | | |
Capitalization
|
| | | | S-23 | | |
Dilution
|
| | | | S-24 | | |
提供的證券説明
|
| | | | S-26 | | |
某些美國聯邦所得税考慮因素
|
| | | | S-29 | | |
Plan of distribution
|
| | | | S-36 | | |
Legal matters
|
| | | | S-38 | | |
Experts
|
| | | | S-38 | | |
您可以在哪裏找到更多信息
|
| | | | S-38 | | |
通過引用併入某些信息
|
| | | | S-38 | | |
| | |
Page
|
| |||
About this prospectus
|
| | | | 1 | | |
Risk factors
|
| | | | 2 | | |
有關前瞻性陳述的告誡聲明
|
| | | | 3 | | |
The company
|
| | | | 5 | | |
Use of proceeds
|
| | | | 7 | | |
Securities we may offer
|
| | | | 8 | | |
股本説明
|
| | | | 9 | | |
債務證券説明
|
| | | | 16 | | |
認股權證説明
|
| | | | 30 | | |
Description of units
|
| | | | 31 | | |
Plan of distribution
|
| | | | 34 | | |
Legal matters
|
| | | | 37 | | |
Experts
|
| | | | 37 | | |
您可以在哪裏找到更多信息
|
| | | | 37 | | |
引用註冊成立
|
| | | | 37 | | |
| | |
12-Month data
|
| |
24-Month data
pooled non- ambulatory pts |
| |
24-Month data
*excluding pts w/scoliosis surgery |
|
HFMSE與基線的平均變化(95%CI)
|
| |
3.6 points
(95% CI: 1.2, 6.0) N=32 |
| |
4.0 points
(95% CI: 1.5, 6.5) N=29 |
| |
4.4 points
(95% CI: 2.0, 6.9) N=28 |
|
RULM中基線的平均變化
(95% CI) |
| |
1.3 points
(95% CI: 0.2, 2.3) N=31 |
| |
1.9 points
(95% CI: 0.8, 3.0) N=33 |
| |
2.3 points
(95% CI: 1.2, 3.4) N=30 |
|
| | |
As of March 31, 2022
|
| |||||||||
(千為單位,共享數據除外)
|
| |
Actual
|
| |
As adjusted
|
| ||||||
現金、現金等價物和有價證券
|
| | | $ | 210,211 | | | | | $ | 405,655 | | |
長期負債總額
|
| | | | 61,288 | | | | | | 61,288 | | |
優先股,面值0.001美元;授權、實際和調整後的10,000,000股,沒有已發行和已發行的股票,實際和調整後的
|
| | | | 0 | | | | | | 0 | | |
普通股,面值0.001美元;授權股份150,000,000股,實際和調整後為35,300,823股;已發行和已發行股份51,627,353股,調整後為51,627,353股
|
| | | | 35 | | | | | | 51 | | |
新增實收資本
|
| | | | 555,513 | | | | | | 750,941 | | |
累計其他綜合收益(虧損)
|
| | | | (152) | | | | | | (152) | | |
Accumulated deficit
|
| | | | (384,080) | | | | | | (384,080) | | |
股東權益總額
|
| | | | 171,316 | | | | | | 366,760 | | |
Total capitalization
|
| | | $ | 232,604 | | | | | $ | 428,048 | | |
|
每股公開發行價和配套普通股認股權證
|
| | | | | | | | | $ | 4.90 | | |
|
截至2022年3月31日的每股有形賬面淨值
|
| | | $ | 4.85 | | | | | | | | |
|
可歸因於此次發行的預計每股有形賬面淨值增加
|
| | | $ | 2.25 | | | | | | | | |
|
本次發售生效後的調整後每股有形賬面淨值的預計值
|
| | | | | | | | | $ | 7.10 | | |
|
參與此次發行的投資者每股有形賬面淨值增加
|
| | | | | | | | | $ | 2.20 | | |
|
| | |
PER SHARE AND
ACCOMPANYING WARRANT |
| |
PER PRE-FUNDED
WARRANT AND ACCOMPANYING WARRANT |
| |
TOTAL
|
| |||||||||
Offering price
|
| | | $ | 4.90 | | | | | $ | 4.8999 | | | | | $ | 204,997,450 | | |
Placement agent fees
|
| | | $ | 0.2205 | | | | | $ | 0.2205 | | | | | $ | 9,224,885 | | |
未扣除費用的收益,歸我們所有
|
| | | $ | 4.6795 | | | | | $ | 4.6794 | | | | | $ | 195,772,565 | | |
| | |
Page
|
| |||
About this Prospectus
|
| | | | 1 | | |
Risk Factors
|
| | | | 2 | | |
有關前瞻性陳述的告誡聲明
|
| | | | 3 | | |
The Company
|
| | | | 5 | | |
Use of Proceeds
|
| | | | 7 | | |
Securities We May Offer
|
| | | | 8 | | |
股本説明
|
| | | | 9 | | |
債務證券説明
|
| | | | 16 | | |
認股權證説明
|
| | | | 30 | | |
Description of Units
|
| | | | 31 | | |
Plan of Distribution
|
| | | | 34 | | |
Legal Matters
|
| | | | 37 | | |
Experts
|
| | | | 37 | | |
您可以在哪裏找到更多信息
|
| | | | 37 | | |
引用註冊成立
|
| | | | 37 | | |
| J.P. Morgan | | |
Piper Sandler
|
|